Jia Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jia Li has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Chunyong He
The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine Shanghai 201203 China
1 shared publicationDong-Xia Li
Country Coconut Research Institute, Chinese Academy of Tropical Agricultural Sciences, Wenchang, China
1 shared publicationHan Gong
Country Coconut Research Institute, Chinese Academy of Tropical Agricultural Sciences, Wenchang, China
1 shared publication- Li Yang
Shanghai Key Laboratory of Compound Chinese Medicines, The MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication Li-Yun Liu
Country Coconut Research Institute, Chinese Academy of Tropical Agricultural Sciences, Wenchang, China
1 shared publicationLin-Kai Wang
Country Coconut Research Institute, Chinese Academy of Tropical Agricultural Sciences, Wenchang, China
1 shared publication
Latest Publications
- 12 August 2026
- Published by Springer Nature in Planta
- Vol. 264 (4) , 95
Forchlorfenuron (CPPU) suppresses fruitlet abscission in Areca catechu by modulating carbohydrate allocation, hormonal dynamics, and lignin biosynthesis
- 12 August 2026
- Published by Springer Nature in Planta
- Vol. 264 (4) , 95
Forchlorfenuron (CPPU) suppresses fruitlet abscission in Areca catechu by modulating carbohydrate allocation, hormonal dynamics, and lignin biosynthesis
- 7 February 2014
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 28 (6) , 595-604
Metabolic profiles of 20( S )‐protopanaxadiol in rats after oral administration using ultra‐performance liquid chromatography/quadrupole time‐of‐flight tandem mass spectrometry
RATIONALE: 20( S )‐Protopanaxadiol (PPD), a dammarane‐type triterpenoid sapogenin, acts as the pharmacophore of ginsenosides which are considered as the principal bioactive components in Chinese ginseng. To fully understand the mechanism of action of PPD, it is important to study its metabolic profiles in vivo . METHODS: Plasma, urine, fece and bile were collected after administration of PPD formulated in 0.5% aqueous Tween‐80 to rats (150 mg/kg). Samples were analyzed by using a sensitive and reliable method based on ultra‐performance liquid chromatography/quadrupole time‐of‐flight tandem mass spectrometry (UPLC/Q‐TOF‐MS/MS) in both positive and negative ion mode. The chemical structures of metabolites were elucidated by comparing the retention time, accurate molecular mass, and fragmentation patterns of analytes with those of PPD. RESULTS: In total 29 metabolites, including 10 new metabolites (M20–M29), were tentatively identified and characterized. Among them, two metabolites (M3 and M4) were unambiguously identified by matching their retention times and fragmentation patterns with their standards. Principal metabolites, namely, 20, 24‐oxide metabolites (M3 and M4), 26/27‐carboxylic acid derivatives (M22 and M23) and a glucuronidated product (M28), were found in the rat plasma. CONCLUSIONS: The results showed that phase I metabolites are monooxygenation, dioxygenation and oxidative dehydrogenation metabolites, and phase II metabolic pathways were demonstrated to be cysteine conjugation and glucuronidation. The newly identified metabolites are useful to understand the mechanism of elimination of PPD and, in turn, its effectiveness and toxicity. Copyright © 2014 John Wiley & Sons, Ltd.
- 7 February 2014
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 28 (6) , 595-604
Metabolic profiles of 20( S )‐protopanaxadiol in rats after oral administration using ultra‐performance liquid chromatography/quadrupole time‐of‐flight tandem mass spectrometry
RATIONALE: 20( S )‐Protopanaxadiol (PPD), a dammarane‐type triterpenoid sapogenin, acts as the pharmacophore of ginsenosides which are considered as the principal bioactive components in Chinese ginseng. To fully understand the mechanism of action of PPD, it is important to study its metabolic profiles in vivo . METHODS: Plasma, urine, fece and bile were collected after administration of PPD formulated in 0.5% aqueous Tween‐80 to rats (150 mg/kg). Samples were analyzed by using a sensitive and reliable method based on ultra‐performance liquid chromatography/quadrupole time‐of‐flight tandem mass spectrometry (UPLC/Q‐TOF‐MS/MS) in both positive and negative ion mode. The chemical structures of metabolites were elucidated by comparing the retention time, accurate molecular mass, and fragmentation patterns of analytes with those of PPD. RESULTS: In total 29 metabolites, including 10 new metabolites (M20–M29), were tentatively identified and characterized. Among them, two metabolites (M3 and M4) were unambiguously identified by matching their retention times and fragmentation patterns with their standards. Principal metabolites, namely, 20, 24‐oxide metabolites (M3 and M4), 26/27‐carboxylic acid derivatives (M22 and M23) and a glucuronidated product (M28), were found in the rat plasma. CONCLUSIONS: The results showed that phase I metabolites are monooxygenation, dioxygenation and oxidative dehydrogenation metabolites, and phase II metabolic pathways were demonstrated to be cysteine conjugation and glucuronidation. The newly identified metabolites are useful to understand the mechanism of elimination of PPD and, in turn, its effectiveness and toxicity. Copyright © 2014 John Wiley & Sons, Ltd.